Lexeo Therapeutics, Inc. (LXEO)
(Delayed Data from NSDQ)
$11.82 USD
+0.05 (0.42%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $11.85 +0.03 (0.25%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Lexeo Therapeutics, Inc. [LXEO]
Reports for Purchase
Showing records 1 - 1 ( 1 total )
Company: Lexeo Therapeutics, Inc.
Industry: Medical - Drugs
Heart and CNS Gene Therapy; 2024 Catalyst Trifecta; Initiate at Buy and $22 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
|